All Stories

  1. Fibroblast plasticity in pulmonary and cardiovascular fibrosis: Mechanistic insights and emerging therapeutic targets
  2. Refining the impact of early intermittent hyperlipidemia on atherosclerosis: Unveiling the role of neutrophil reprogramming, sex differences, gut microbiota, and maternal hypercholesterolemia
  3. Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice
  4. Agreement on the Prevalence of Body Mass Index (BMI) in Mexican Children and Adolescents Using Different International References
  5. Comment on: “Impaired Ischemia-Reperfusion Responses in the Hearts of Aged Male and Female Offspring of Obese Rats”
  6. Bridging translational gaps in Mexico’s new science era
  7. Atrial Fibrillation Advances in Asia
  8. Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths
  9. ADAR1 Isoforms Regulate Let-7d Processing in Idiopathic Pulmonary Fibrosis
  10. Remote ischemic preconditioning in patients undergoing cardiac surgery with six ischemic cycles
  11. Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation
  12. Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
  13. Editorial: New Advances in RNA Targeting
  14. Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?
  15. Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
  16. Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation
  17. Chronic inflammatory diseases, myocardial function and cardioprotection
  18. Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
  19. Obesity subtypes, related biomarkers & heterogeneity
  20. Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study
  21. Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
  22. Role of Macrophages in Cardioprotection
  23. Immune cells as targets for cardioprotection: New players and novel therapeutic opportunities
  24. FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice
  25. Circulating blood cells and extracellular vesicles in acute cardioprotection
  26. Innate immunity as a target for acute cardioprotection
  27. Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned Enigma
  28. Diagnosis of Transient/Latent HPV Infections - A Point of View!
  29. Impact of Cardioprotective Therapies on the Edema-Based Area at Risk by CMR in Reperfused STEMI
  30. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
  31. The Role of Redox Dysregulation in the Inflammatory Response to Acute Myocardial Ischaemia-reperfusion Injury - Adding Fuel to the Fire
  32. Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality
  33. Assessing the effects of mitofusin 2 deficiency in the adult heart using 3D electron tomography
  34. Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping
  35. Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice
  36. Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
  37. Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”
  38. Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes
  39. MicroRNA‐142 is a multifaceted regulator in organogenesis, homeostasis, and disease
  40. Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients
  41. Reply
  42. Antitumor Macrophage Response to Bacillus pumilus Ribonuclease (Binase)
  43. Filing Sources after Oral P<sub>2</sub>Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS)
  44. Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
  45. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
  46. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”
  47. Index of Microvascular Resistance and Microvascular Obstruction in Patients With Acute Myocardial Infarction
  48. Influence of Extracellular RNAs, Released by Rheumatoid Arthritis Synovial Fibroblasts, on Their Adhesive and Invasive Properties
  49. Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside
  50. Polysialylation takes place in granulosa cells during apoptotic processes of atretic tertiary follicles
  51. Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease
  52. Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats
  53. Regulation of monocyte/macrophage polarisation by extracellular RNA
  54. Inflammation between defense and disease: impact on tissue repair and chronic sickness
  55. Attenuation of Myocardial Ischemia/Reperfusion Reaction by RNAse1 Treatment
  56. Role of the MPTP in conditioning the heart – translatability and mechanism
  57. RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection
  58. Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges
  59. Bacillus intermedius ribonuclease (BINASE) induces apoptosis in human ovarian cancer cells
  60. Response to Letter Regarding Article “Role of Extracellular RNA in Atherosclerotic Plaque Formation in Mice”
  61. 008 * RNASE1 AS A POTENTIAL MEDIATOR OF REMOTE ISCHAEMIC PRECONDITIONING FOR CARDIOPROTECTION
  62. Characterization of rapid neutrophil extracellular trap formation and its cooperation with phagocytosis in human neutrophils
  63. P166Extracellular RNA in cardiac ischemia/reperfusion injury: prevention of heart failure and cell damage by RNase1
  64. P735Regulation of macrophage polarization by extracellular RNA: The role of sialoadhesin-1
  65. C0266: Regulation of Macrophage Polarization by Extracellular RNA: The Role of Sialoadhesin-1
  66. Impact of extracellular RNA on endothelial barrier function
  67. Cyclospora cayetanensis: This Emerging Protozoan Pathogen in Mexico
  68. Role of Extracellular RNA in Atherosclerotic Plaque Formation in Mice
  69. Hmga2 is required for canonical WNT signaling during lung development
  70. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury
  71. Thrombin selectively induces transcription of genes in human monocytes involved in inflammation and wound healing
  72. Quantitative Proteome Analysis of Alveolar Type-II Cells Reveals a Connection of Integrin Receptor Subunits Beta 2/6 and WNT Signaling
  73. Influence of chronic food deprivation on structure–function relationship of juvenile rat fast muscles
  74. Internalization of Bacillus intermedius ribonuclease (BINASE) induces human alveolar adenocarcinoma cell death
  75. Binase penetration into alveolar epithelial cells does not induce cell death
  76. 18. Comparative Toxicity of Binase towards Tumor and Normal Cells
  77. Binase penetration into alveolar epithelial cellsdoes not induce cell death